Implications of cell division cycle associated 4 on the Wilm’s tumor cells viability via AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implications of cell division cycle associated 4 on the Wilm’s tumor cells viability via AKT/mTOR signaling pathway

Published:2021-01-01 Issue:1 Volume:43 Page:1470-1478
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Li Suqing¹,Qin Cong¹,Chen Yike¹,Wei Dan²,Tan Zhijun¹,Meng Jiadong¹

Affiliation:

1. Department of Pediatrics, Guigang City People’s Hospital, the Eight Affiliated Hospital of Guangxi Medical University, Guigang, P.R. China

2. Department of Pediatrics, the First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2021.1994994

Reference33 articles.

2. The yin and yang of kidney development and Wilms’ tumors

3. Controversies and advances in the management of Wilms' tumour

4. Biomarkers for Wilms Tumor: A Systematic Review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cell division cycle-associated proteins in regulating cell cycle and promoting tumor progression;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy;Frontiers in Immunology;2023-11-30

3. CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway;Thoracic Cancer;2023-02-03

4. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma;Frontiers in Oncology;2022-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3